COG AALL1331: A Risk-Stratified Randomized Phase III Testing of Blinatumomab (IND# 117467, NSC#765986) in First Relapse of Childhood B-Lymphoblastic Leukemia (B-ALL)

  • Hijiya, Nobuko (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date10/16/15 → 12/31/19

Funding

  • Children’s Hospital of Philadelphia (WO FP#: FP00017990_SUB24_01)
  • Amgen, Inc. (WO FP#: FP00017990_SUB24_01)